Medicare Enrolled
Dr. James Fitzgerald, M.D.
Urology Physician · North Easton, MA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Fitzgerald from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Fitzgerald?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Fitzgerald
Dr. James Fitzgerald is an urology physician in North Easton, MA, with 21 years of NPI registration. Based on federal Medicare data, Dr. Fitzgerald performed 8,707 Medicare services across 4,076 unique beneficiaries.
Between the years covered by Open Payments, Dr. Fitzgerald received a total of $14,529 from 71 pharmaceutical and/or device companies across 505 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Fitzgerald is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 21 years in practice
▲ Top 7% volume in MA
$14,529 industry payments
Medicare Practice Summary
Medicare Utilization ↗8,707
Medicare services
Top 7% in MA for urology physician
4,076
Unique beneficiaries
$48
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~415 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Infectious disease DNA/RNA test A laboratory test that uses a specific technique to detect the genetic material of an organism. This method amplifies the target DNA or RNA to identify the presence of the organism. |
2,353 | $34 | $85 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
1,385 | $2 | $20 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,070 | $93 | $350 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
623 | $8 | $50 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
467 | $68 | $245 |
| Complete ultrasound of retroperitoneum An ultrasound examination of the structures located behind the abdominal cavity. |
363 | $51 | $257 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
252 | $8 | $25 |
| PSA test (prostate cancer screening) | 240 | $18 | $100 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
235 | $49 | $85 |
| VRE nucleic acid detection test A laboratory test that uses amplified probe techniques to detect vancomycin-resistant Enterococcus (VRE) DNA in a patient sample. |
181 | $34 | $85 |
| Staphylococcus aureus DNA test A laboratory test that uses DNA amplification to detect the presence of Staphylococcus aureus bacteria in a sample. |
181 | $34 | $85 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
171 | $122 | $478 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
167 | $176 | $725 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 151 | $135 | $750 |
| Lower leg neurostimulator electrode insertion A procedure to place an electrode in the lower leg for neurostimulation therapy. |
122 | $96 | $387 |
| Nucleic acid test for multiple organisms A laboratory test that uses amplified probe techniques to detect the genetic material of multiple organisms in a sample. |
120 | $69 | $175 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
106 | $67 | $273 |
| Simple insertion of temporary bladder tube A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder. |
103 | $48 | $300 |
| Free PSA test A blood test that measures the amount of unbound prostate-specific antigen in the blood. |
69 | $18 | $100 |
| Chronic care management, additional 20 min/month This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month. |
69 | $38 | $85 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
61 | $6 | $282 |
| Ultrasound of scrotum An imaging test that uses sound waves to create pictures of the scrotum and its contents. It helps evaluate the testicles and surrounding structures. |
30 | $48 | $192 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
29 | $11 | $90 |
| Bladder irrigation and/or instillation This procedure involves flushing the bladder with fluid to clear it or introducing medication directly into the bladder. |
26 | $61 | $289 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
26 | $96 | $375 |
| Injection, garamycin, gentamicin, up to 80 mg | 26 | $2 | $15 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
20 | $156 | $800 |
| Blood creatinine level test A blood test that measures the amount of creatinine, a waste product from muscle wear and tear, to help assess kidney function. |
17 | $5 | $20 |
| Blood urea nitrogen test A blood test that measures the amount of urea nitrogen to assess kidney function. |
17 | $4 | $15 |
| Injection of biodegradable material next to prostate A procedure involving the injection of a biodegradable substance into the tissue surrounding the prostate gland. |
15 | $2,437 | $9,000 |
| Total testosterone level test A blood test that measures the total amount of testosterone in your body. This hormone is important for various bodily functions in both men and women. |
12 | $23 | $89 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$14,529
Total received (2018-2024)
Avg $2,076/year across 7 years
Top 12% in MA for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
71
Companies
505
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,272 (91.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,257 (8.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,175
2023
$1,977
2022
$3,561
2021
$1,494
2020
$999
2019
$2,521
2018
$1,802
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Tolmar, Inc.
$216
DENTSPLY IH AB
$207
ABBVIE INC.
$187
Teleflex LLC
$181
Sumitomo Pharma America, Inc.
$127
Ferring Pharmaceuticals Inc.
$117
Endo USA, Inc.
$107
Myriad Genetic Laboratories, Inc.
$93
Antares Pharma, Inc.
$87
180 Medical, Inc.
$84
ACCORD HEALTHCARE, INC.
$70
UROGEN PHARMA, INC.
$66
Laborie Medical Technologies Corp.
$66
COLOPLAST CORP
$61
Endo Pharmaceuticals Inc.
$61
IMMUNITYBIO, INC.
$59
ABC Home Medical Supply, Inc.
$52
PROGENICS PHARMACEUTICALS, INC.
$50
C. R. Bard, Inc. & Subsidiaries
$43
Astellas Pharma US Inc
$41
PFIZER INC.
$32
Hollister Incorporated
$27
PROCEPT BioRobotics Corporation
$26
Janssen Biotech, Inc.
$26
BIOPROTECT MEDICAL, INC.
$26
Merck Sharp & Dohme LLC
$25
Boston Scientific Corporation
$24
Olympus America Inc.
$13
Top 3 companies account for 28.1% of 2024 payments
All-time payments by company (2018-2024) ›
Teleflex LLC
$2,039
Astellas Pharma US Inc
$1,815
NeoTract Inc.
$1,619
Endo Pharmaceuticals Inc.
$790
Antares Pharma, Inc.
$660
PFIZER INC.
$598
Dendreon Pharmaceuticals LLC
$447
Janssen Biotech, Inc.
$446
Myriad Genetic Laboratories, Inc.
$391
DENTSPLY IH AB
$371
Tolmar, Inc.
$340
Sumitomo Pharma America, Inc.
$316
BOSTON SCIENTIFIC CORPORATION
$306
Avadel Specialty Pharmaceuticals, LLC
$285
180 Medical, Inc.
$274
ABBVIE INC.
$266
Laborie Medical Technologies Corp.
$185
UROVANT SCIENCES INC
$163
Boston Scientific Corporation
$158
Augmenix, Inc.
$156
TOLMAR Pharmaceuticals, Inc.
$147
Acerus Pharmaceuticals Corporation
$136
AbbVie Inc.
$134
Progenics Pharmaceuticals, Inc.
$133
Blue Earth Diagnostics Limited
$130
UroGen Pharma, Inc.
$122
Ferring Pharmaceuticals Inc.
$117
Endo USA, Inc.
$107
COLOPLAST CORP
$93
AbbVie, Inc.
$91
Rochester Medical Corporation
$88
UROGEN PHARMA, INC.
$86
Hollister Incorporated
$83
C. R. Bard, Inc. & Subsidiaries
$81
Myovant Sciences Inc.
$79
Allergan, Inc.
$74
PROCEPT BioRobotics Corporation
$73
ACCORD HEALTHCARE, INC.
$70
Mission Pharmacal Company
$62
Coloplast Corp
$60
IMMUNITYBIO, INC.
$59
Amgen Inc.
$56
ConvaTec Inc.
$55
ABC Home Medical Supply, Inc.
$52
PROGENICS PHARMACEUTICALS, INC.
$50
Sun Pharmaceutical Industries Inc.
$45
Kowa Pharmaceuticals America, Inc.
$45
GENZYME CORPORATION
$41
Olympus America Inc.
$39
C. R. BARD, INC. & SUBSIDIARIES
$36
Axonics, Inc.
$36
Bayer HealthCare Pharmaceuticals Inc.
$32
HealthTronics Mobile Solutions, LLC
$30
AstraZeneca Pharmaceuticals LP
$28
BIOPROTECT MEDICAL, INC.
$26
Merck Sharp & Dohme LLC
$25
Agiliti Surgical, Inc.
$25
Janssen Scientific Affairs, LLC
$23
Telix Pharmaceuticals
$23
E.R. Squibb & Sons, L.L.C.
$21
Palette Life Sciences, Inc.
$21
Novartis Pharmaceuticals Corporation
$21
Metuchen Pharmaceuticals
$20
Medtronic USA, Inc.
$19
Axonics Modulation Technologies, Inc.
$19
TherapeuticsMD, Inc.
$17
DENTSPLY IH Inc.
$17
Allergan Inc.
$16
Alnylam Pharmaceuticals Inc.
$15
Egalet US Inc
$14
Valencia Technologies Corporation
$13
Top 3 companies account for 37.7% of all-time payments
Associated products mentioned in payments ›
ADSTILADRIN · AMS · ANKTIVA · AQUABEAM ROBOTIC SYSTEM · AQUABEAM SYSTEM · AVEED · Androgel · Axonics · Axonics r-SNM System · Axumin · BIOPROTECT BALLOON IMPLANT SYSTEM · BOTOX · BRACANALYSIS CDX · BRACAnalysis CDx · Bard Urinary Drainage Bag · Bulkamid · CAMCEVI · CURE CATHETER · CYSTO-NEPHRO VIDEOSCOPE · ELIGARD · ERLEADA · Erleada · GEMTESA · GENERAL - FEMALE SUI · GENERAL BPH · GENTLECATH · GENTLECATH GLIDE · GREENLIGHT · GentleCath · ILLUCCIX · IMVEXXY · INTERSTIM · Infyna Chic · JELMYTO · JEVTANA · KEYTRUDA · LOFRIC · LUPRON DEPOT · LYNPARZA · Livalo · LoFric · Lumenis Pulse 120H · Lupron Depot · MAGIC3 · MYRBETRIQ · Mobile Laser Services · Myrbetriq · NOCDURNA · Natesto · Noctiva · Nubeqa · OPDIVO · ORGOVYX · OTREXUP · OXLUMO · Optilume BPH Drug Coated Balloon Catheter · PROLARIS · PROVENGE · PVC · PYLARIFY · Percutaneous Solutions: PERCUVANCE & MiniLap brands · Prolaris · Prolia · REZUM · SOLYX · SPEEDICATH · SPRIX · Seglentis · Solyx SIS System · Sonablate · SpaceOAR · SpeediCath · Stendra · TOVIAZ · Titan · URIBEL · UROLIFT · Uribel · UroLift · UroLift System · VaPro · XIAFLEX · XTANDI · XYOSTED · Xtandi · YONSA · YONSA (abiraterone acetate) · eCoin Device Kit · iTIND System · myRisk
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (91%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Urology physicians within 10 mi
214
Per 100K population
37.0
County median income
$84,198
Nearest hospital
GOOD SAMARITAN MEDICAL CENTER
4.2 mi
4.2 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Fitzgerald is a clinical cardiology specialist, with above-average Medicare volume (top 7% in MA), with low-engagement industry engagement in the top 12% of MA peers, with 21 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Fitzgerald experienced with infectious disease dna/rna test?
Based on Medicare claims data, Dr. Fitzgerald performed 2,353 infectious disease dna/rna test services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Fitzgerald receive payments from pharmaceutical companies?
Yes. Dr. Fitzgerald received a total of $14,529 from 71 companies across 505 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Fitzgerald's costs compare to other urology physicians in North Easton?
Dr. Fitzgerald's average Medicare payment per service is $48. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Fitzgerald) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in North Easton
Browse urology physicians in North Easton ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in MA
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in MA
Which MA urology physicians receive the most from drug and device companies.
By company
Teleflex LLC Payments to Doctors
See all physicians who received payments from Teleflex LLC.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
NeoTract Inc. Payments to Doctors
See all physicians who received payments from NeoTract Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology